+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2022
  • Region: Global
  • Grand View Research
  • ID: 5712527
The global laboratory developed tests market size is expected to reach USD 16.72 billion by 2030, expanding at a CAGR of 6.58% from 2023 to 2030. The growth of the industry is attributed to the increasing prevalence of chronic and genetic diseases, infectious & autoimmune diseases, and rising awareness among the population about healthy living. The laboratory-developed tests (LDTs) are generated and utilized in the laboratories, and LDTs are released into the market without FDA approval or any other independent regulatory assessment. LDTs are most typically employed in molecular diagnostics, which includes tests that target a variety of different chemicals in addition to genetics.

For instance, in July 2022, Quest Diagnostics launched a lab-based molecular diagnostic test for the diagnosis of monkeypox virus infections. Moreover, immunoassay is gaining immense adoption and acceptability with the development of novel tests. For instance, in December 2021, OPKO Health, Inc., announced the FDA approval of the 4Kscore test, an LDT in which, four immunoassays are combined into a single numerical score that takes into account the patient’s age, biopsy history, and the results of a digital rectal exam. Although LDTs do not require FDA approval as they are not marketed to others, they need to go through rigorous validation procedures. However, the increasing global prevalence of cancer is a key factor driving the industry's growth.

According to GLOBOCAN, in 2020, there were an estimated 19.3 million new cancer cases globally, out of which, 2.3 million were breast cancer cases. Lung cancer was the most common cause of death among cancer patients, representing an unmet need for faster and more accurate diagnostic tools in the segment. In January 2021, the British In Vitro Diagnostics Association urged NHS England for the development of a commissioning framework for molecular diagnostics in oncology. Key players focus on product launches and geographical expansion to gain a higher industry share. For instance, in May 2022, Guardant Health launched Shield, a blood test that is available as an LDT for the detection of early signs of colorectal cancer in the adult population aged above 45 years

Laboratory Developed Tests Market Report Highlights

  • The molecular diagnostic technology segment dominated the industry and accounted for the largest share of the overall revenue in 2021
  • The segment growth was attributed to the increased need to provide diagnostics tests for a number of diseases
  • The oncology application segment is expected to grow lucratively over the forecast period due to the increasing prevalence of cancer
  • The market is expected to grow significantly owing to the introduction of innovative services that can address the growing demands of the target audience
  • North America dominated the industry in 2021 owing to the introduction of novel LDT products and the high demand for diagnostics tools with the increasing geriatric population


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Laboratory Developed Tests Market

What is the estimated value of the Global Laboratory Developed Tests Market?

The Global Laboratory Developed Tests Market was estimated to be valued at $10.3 Billion in 2023.

What is the growth rate of the Global Laboratory Developed Tests Market?

The growth rate of the Global Laboratory Developed Tests Market is 6.5%, with an estimated value of $16.72 Billion by 2030.

What is the forecasted size of the Global Laboratory Developed Tests Market?

The Global Laboratory Developed Tests Market is estimated to be worth $16.72 Billion by 2030.

Who are the key companies in the Global Laboratory Developed Tests Market?

Key companies in the Global Laboratory Developed Tests Market include Quest Diagnostics Incorporated, 23andme, Inc., Abbott, Guardant Health, NeoGenomics Laboratories, Siemens Healthcare Private Limited., QIAGEN, Eurofins Scientific and F. Hoffmann.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Laboratory Developed Tests Market Variables, Trends, & Scope
3.1 Laboratory Developed Tests Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (IVD) Market
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.4 Market Driver Analysis
3.4.1 Increasing demand for in vitro diagnostic tests that are currently unavailable in the market
3.4.2 Increasing demand for development of personalized medicine
3.4.3 No requirement for any regulatory approval.
3.5 Market Restraint Analysis
3.5.1 High cost associated with the laboratory-developed test
3.5.2 Efficacy and safety issues related to LDT
3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 Laboratory Developed Tests Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)
4.1 Laboratory Developed Tests Market: Technology Movement Analysis
4.1.1 Immunoassays
4.1.1.1 Immunoassays Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.2 Hematology and Coagulation
4.1.2.1 Hematology And Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3 Molecular Diagnostics
4.1.3.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4 Microbiology
4.1.4.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.5 Clinical Chemistry
4.1.5.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.6 Histology/Cytology
4.1.6.1 Histology/Cytology Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.7 Flow Cytometry
4.1.7.1 Flow Cytometry Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.8 Mass Spectroscopy
4.1.8.1 Mass Spectroscopy Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.9 Others
4.1.9.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Laboratory Developed Tests Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Laboratory Developed Tests Market: Application Movement Analysis
5.1.1 Oncology
5.1.1.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.1.2 Companion Diagnostics
5.1.1.3 Companion Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.1.4 Genomic Sequencing and Others
5.1.1.5 Genomic Sequencing and Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.2 Genetic Disorders/Inherited Disease
5.1.2.1 Genetic Disorders/Inherited Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.3 Infectious And Parasitic Diseases
5.1.3.1 Infectious And Parasitic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.4 Immunology
5.1.4.1 Immunology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.5 Endocrine
5.1.5.1 Endocrine Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.6 Nutritional And Metabolic Disease
5.1.6.1 Nutritional And Metabolic Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.7 Cardiology
5.1.7.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.8 Mental/Behavioral Disorder
5.1.8.1 Mental/Behavioral Disorder Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.9 Pediatrics-specific Testing
5.1.9.1 Pediatrics-specific Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.10 Hematology/General Blood Testing
5.1.10.1 Hematology/General Blood Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.11 Bodily Fluid Analysis
5.1.11.1 Bodily Fluid Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.12 Toxicology
5.1.12.1 Toxicology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.13 Other Diseases
5.1.13.1 Other Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 RegionalL Business Analysis
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
6.5.1 North America
6.5.2 Europe
6.5.3 Asia Pacific
6.5.4 Latin America
6.5.5 MEA
6.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
6.7 North America
6.7.1 North America Market Estimates And Forecas, 2018 - 2030 (USD Million)
6.7.2 U.S.
6.7.2.1 U.S. Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.7.2.2 Key country Dynamics
6.7.2.3 Regulatory Framework
6.7.2.4 Competitive Scenario
6.7.2.5 Recent Developments
6.7.2.6 Investments Scenario
6.7.3 Canada
6.7.3.1 Canada Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.7.3.2 Key country Dynamics
6.7.3.3 Regulatory Framework
6.7.3.4 Competitive Scenario
6.7.3.5 Recent Developments
6.7.3.6 Investments Scenario
6.8 Europe
6.8.1 Europe Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.2 U.K.
6.8.2.1 U.K. Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.2.2 Key country Dynamics
6.8.2.3 Regulatory Framework
6.8.2.4 Competitive Scenario
6.8.2.5 Recent Developments
6.8.2.6 Investments Scenario
6.8.3 Germany
6.8.3.1 Germany Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.3.2 Key country Dynamics
6.8.3.3 Regulatory Framework
6.8.3.4 Competitive Scenario
6.8.3.5 Recent Developments
6.8.3.6 Investments Scenario
6.8.4 Spain
6.8.4.1 Spain Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.4.2 Key country Dynamics
6.8.4.3 Regulatory Framework
6.8.4.4 Competitive Scenario
6.8.4.5 Recent Developments
6.8.4.6 Investments Scenario
6.8.5 France
6.8.5.1 France Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.5.2 Key country Dynamics
6.8.5.3 Regulatory Framework
6.8.5.4 Competitive Scenario
6.8.5.5 Recent Developments
6.8.5.6 Investments Scenario
6.8.6 Italy
6.8.6.1 Italy Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.6.2 Key country Dynamics
6.8.6.3 Regulatory Framework
6.8.6.4 Competitive Scenario
6.8.6.5 Recent Developments
6.8.6.6 Investments Scenario
6.8.7 Denmark
6.8.7.1 Denmark Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.7.2 Key country Dynamics
6.8.7.3 Regulatory Framework
6.8.7.4 Competitive Scenario
6.8.7.5 Recent Developments
6.8.7.6 Investments Scenario
6.8.8 Sweden
6.8.8.1 Sweden Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.8.2 Key country Dynamics
6.8.8.3 Regulatory Framework
6.8.8.4 Competitive Scenario
6.8.8.5 Recent Developments
6.8.8.6 Investments Scenario
6.8.9 Norway
6.8.9.1 Norway Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.8.9.2 Key country Dynamics
6.8.9.3 Regulatory Framework
6.8.9.4 Competitive Scenario
6.8.9.5 Recent Developments
6.8.9.6 Investments Scenario
6.9 Asia Pacific
6.9.1 Asia-Pacific Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.2 Japan
6.9.2.1 Japan Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.2.2 Key country Dynamics
6.9.2.3 Regulatory Framework
6.9.2.4 Competitive Scenario
6.9.2.5 Recent Developments
6.9.2.6 Investments Scenario
6.9.3 China
6.9.3.1 China Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.3.2 Key country Dynamics
6.9.3.3 Regulatory Framework
6.9.3.4 Competitive Scenario
6.9.3.5 Recent Developments
6.9.3.6 Investments Scenario
6.9.4 India
6.9.4.1 India Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.4.2 Key country Dynamics
6.9.4.3 Regulatory Framework
6.9.4.4 Competitive Scenario
6.9.4.5 Recent Developments
6.9.4.6 Investments Scenario
6.9.5 South Korea
6.9.5.1 South Korea Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.5.2 Key country Dynamics
6.9.5.3 Regulatory Framework
6.9.5.4 Competitive Scenario
6.9.5.5 Recent Developments
6.9.5.6 Investments Scenario
6.9.6 Thailand
6.9.6.1 Thailand Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.6.2 Key country Dynamics
6.9.6.3 Regulatory Framework
6.9.6.4 Competitive Scenario
6.9.6.5 Recent Developments
6.9.6.6 Investments Scenario
6.9.7 Australia
6.9.7.1 Australia Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.9.7.2 Key country Dynamics
6.9.7.3 Regulatory Framework
6.9.7.4 Competitive Scenario
6.9.7.5 Recent Developments
6.9.7.6 Investments Scenario
6.10 Latin America
6.10.1 Latin America Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.10.2 Brazil
6.10.2.1 Brazil Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.10.2.2 Key country Dynamics
6.10.2.3 Regulatory Framework
6.10.2.4 Competitive Scenario
6.10.2.5 Recent Developments
6.10.2.6 Investments Scenario
6.10.3 Mexico
6.10.3.1 Mexico Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.10.3.2 Key country Dynamics
6.10.3.3 Regulatory Framework
6.10.3.4 Competitive Scenario
6.10.3.5 Recent Developments
6.10.3.6 Investments Scenario
6.10.4 Argentina
6.10.4.1 Argentina Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.10.4.2 Key country Dynamics
6.10.4.3 Regulatory Framework
6.10.4.4 Competitive Scenario
6.10.4.5 Recent Developments
6.10.4.6 Investments Scenario
6.11 MEA
6.11.1 MEA Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.11.2 South Africa
6.11.2.1 South Africa Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.11.2.2 Key country Dynamics
6.11.2.3 Regulatory Framework
6.11.2.4 Competitive Scenario
6.11.2.5 Recent Developments
6.11.2.6 Investments Scenario
6.11.3 Saudi Arabia
6.11.3.1 Saudi Arabia Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.11.3.2 Key country Dynamics
6.11.3.3 Regulatory Framework
6.11.3.4 Competitive Scenario
6.11.3.5 Recent Developments
6.11.3.6 Investments Scenario
6.11.4 UAE
6.11.4.1 UAE Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.11.4.2 Key country Dynamics
6.11.4.3 Regulatory Framework
6.11.4.4 Competitive Scenario
6.11.4.5 Recent Developments
6.11.4.6 Investments Scenario
6.11.5 Kuwait
6.11.5.1 Kuwait Laboratory Developed Tests Market, 2018 - 2030 (USD Million)
6.11.5.2 Key country Dynamics
6.11.5.3 Regulatory Framework
6.11.5.4 Competitive Scenario
6.11.5.5 Recent Developments
6.11.5.6 Investments Scenario
Chapter 7 Competitive Analysis
7.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
7.2 Strategy Framework
7.3 Market Participation Categorization
7.4 Recent Developments & Impact Analysis, by Key Market Participants
7.5 Company Position Analysis
7.6 List of Distributors
7.6.1 Key Customers
7.6.2 Public Companies
7.6.3 Private Companies
Chapter 8 Company Profiles
8.1 Quest Diagnostics Incorporated
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 23andme, Inc.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 Abbott
8.3.1 Company Overview
8.2.2 Financial Performance
8.3.2 Product Benchmarking
8.9.4 Strategic Initiatives
8.4 Guardant Health
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 NeoGenomics Laboratories
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Siemens Healthcare Private Limited.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.2 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 QIAGEN
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Eurofins Scientific
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.9 Illumina, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Laboratory Developed Tests Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 6 Global Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 7 North America Laboratory Developed Tests Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 9 North America Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 10 U.S. Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 11 U.S. Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 12 Canada Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 13 Canada Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 14 Europe Laboratory Developed Tests Market, By Country, 2018 - 2030 (USD Million)
Table 15 Europe Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 16 Europe Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 17 U.K. Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 18 U.K. Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 19 Germany Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 20 Germany Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 21 France Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 22 France Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 23 Spain Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 24 Spain Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 25 Italy Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 26 Italy Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 27 Denmark Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 28 Denmark Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 29 Sweden Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 30 Sweden Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 31 Norway Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 32 Norway Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Laboratory Developed Tests Market, By Country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 36 Japan Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 37 Japan Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 38 China Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 39 China Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 40 Australia Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 41 Australia Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 42 Thailand Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 43 Thailand Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 44 India Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 45 India Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 46 South Korea Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 47 South Korea Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 48 Latin America Laboratory Developed Tests Market, By Country, 2018 - 2030 (USD Million)
Table 49 Latin America Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 50 Latin America Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 51 Mexico Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 52 Mexico Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 53 Brazil Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 54 Brazil Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 55 Argentina Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 56 Argentina Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 57 MEA Laboratory Developed Tests Market, By Country, 2018 - 2030 (USD Million)
Table 58 MEA Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 59 MEA Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 60 South Africa Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 61 South Africa Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 62 South Africa Laboratory Developed Tests Market, By End-use, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 64 Saudi Arabia Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 65 UAE Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 66 UAE Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
Table 67 Kuwait Laboratory Developed Tests Market, By Technology, 2018 - 2030 (USD Million)
Table 68 Kuwait Laboratory Developed Tests Market, By Application, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Laboratory developed test market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Laboratory developed test market snapshot
Fig. 10 Penetration and growth prospect mapping for application, 2021 (USD million)
Fig. 11 Market Dynamics
Fig. 12 Laboratory developed test market driver impact
Fig. 13 Laboratory developed test market restraint impact
Fig. 14 Porter’s five forces analysis
Fig. 15 Laboratory developed test market: Technology outlook and key takeaways
Fig. 16 Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Hematology and coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Histology/Cytology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Mass Spectroscopy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Laboratory developed test market : Application outlook and key takeaways
Fig. 26 Laboratory developed test market: Application movement analysis
Fig. 27 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Genetic disorder/Inherited disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Infectious and parasitic disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Endocrine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Nutritional and metabolic disease market estimates and forecast,, 2018 - 2030 (USD Million)
Fig. 33 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Mental/Behavioral disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Pediatric-specific testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Hematology/General blood testing market estimates and forecast,, 2018 - 2030 (USD Million)
Fig. 37 Bodily fluid analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Toxicology market estimates and forecast,, 2018 - 2030 (USD Million)
Fig. 39 Others disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Laboratory Developed Tests Market: Regional outlook and key takeaways
Fig. 41 Breast cancer liquid biopsy: Regional movement analysis
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Europe
Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 U.K.
Fig. 51 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Germany
Fig. 53 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 France
Fig. 55 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain
Fig. 57 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Denmark
Fig. 61 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Sweden
Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Norway
Fig. 65 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Asia Pacific
Fig. 67 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Japan
Fig. 69 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 China
Fig. 71 China. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 India
Fig. 73 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Australia
Fig. 75 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Thailand
Fig. 77 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 South Korea
Fig. 79 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Latin America
Fig. 81 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Brazil
Fig. 83 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Mexico
Fig. 85 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Argentina
Fig. 87 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 MEA
Fig. 89 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 South Africa
Fig. 91 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia
Fig. 93 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 UAE
Fig. 95 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Kuwait
Fig. 97 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 98 Ansoff Matrix
Fig. 99 Strategy mapping
Fig. 100 Company market share analysis, 2021
Fig. 101 Heat Map Analysis
Fig. 102 Market differentiators
Fig. 103 Heat Map Analysis

Companies Mentioned

  • Quest Diagnostics Incorporated
  • 23andme, Inc.
  • Abbott
  • Guardant Health
  • NeoGenomics Laboratories
  • Siemens Healthcare Private Limited.
  • QIAGEN
  • Eurofins Scientific
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...